PR Newswire
17 Jun 2022, 06:20 GMT+10
HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK") recently announced that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND") application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib. Details related to this news can be found via the following Cellenkos news announcement:
Ms. Ting Zheng, Chief Executive Officer and Chairperson of GCBC commented, "The Global Cord Blood team is encouraged by the above news announced by CLNK which highlights a potentially transformative treatment for myelofibrosis patients. We congratulate CLNK team on this development."
About Global Cord Blood Corporation
Global Cord Blood Corporation is an umbilical cord blood banking operator serving multiple regions in China. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at: http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: William.zima@icrinc.com
SOURCE Global Cord Blood Corporation
Get a daily dose of Philippine Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Philippine Times.
More InformationKIYIV, Ukraine: While visiting Ukraine this week, Prime Minister Anthony Albanese said Australia will ban Russian gold imports and provide ...
BERLIN, Germany: Karl Lauterbach, Germany's health minister, has said that he will encourage family doctors to issue more prescriptions for ...
PARIS, France: According to projections and interviews by the Associated Press in 11 countries, tourism officials have said they expect ...
TRENTO, Italy: Record warm temperatures caused a mountain glacier in the Italian Alps to collapse on July 3, killing at ...
WASHINGTON D.C.: The Department of Homeland Security (DHS) will assist Qatar with security during the 2022 World Cup, which begins ...
PARIS, France: Signaling further disruptions for summer travelers, workers at Roissy-Charles de Gaulle Airport said they would go on strike ...
LONDON, England: Amidst surging energy prices and worker shortages, research released this week showed the number of pubs in England ...
BERLIN, Germany: Higher import figures saw Germany recording its first monthly trade deficit in May since 1991. Exports amounted to ...
NEW YORK, New York - The U.S. stock markets again edged in and out of positive territory on Wednesday, but ...
BRUSSELS, Belgium: A document released by the European Union this week revealed that the bloc and its development finance institutions ...
WARSAW, Poland: As Poland's main interest rate remains at its highest level since 2008, boosting the profits of Polish banks, ...
SYDNEY, NSW, Australia - Stocks across Asia lost ground on Wednesday, although the New Zealand market defied the regional trend ...